FUTURE OF CAROTID ENDARTERECTOMY IN ASYMPTOMATIC PATIENTS

Friday, November 6, 2020
12:00 - 1:15 PM EST (5:00 - 6:15 PM GMT)
____________________

Moderator:
Ali F. AbuRahma, MD
Member, VEITHsymposium Advisory Committee
Professor of Surgery
Chief of Vascular & Endovascular Surgery
Director, Vascular Surgery Fellowship & Residency
West Virginia University
Medical Director, Vascular Laboratory
Co-Director, Vascular Center of Excellence
Charleston Area Medical Center
Charleston, West Virginia
____________________

Co-Moderator:
Frank J. Veith, MD
Chairman, VEITHsymposium
____________________

Distinguished Panel:

Anne L. Abbott, MD, PhD, FRACP
Associate Professor
Monash University
Neurologist
Knox Private
Melbourne, Australia

Nearly All Asymptomatic Stenosis Patients Should Be Treated Medically: Just Look at the Data!
____________________

Enrico Ascher, MD
Co-Chairman, VEITHsymposium
Professor of Surgery
New York University
Chief, Division of Vascular Surgery
NYU Langone Brooklyn
New York, New York

Mini-Incision CEA May Be Safer and More Cost Effective Than T-CAR or Transfemoral CAS
____________________

Richard P. Cambria, MD
The Robert R. Linton MD Professor of Vascular and Endovascular Surgery
Harvard Medical School
Chief, Division of Vascular and Endovascular Surgery
St. Elizabeth Medical Center
Brighton, Massachusetts

The Majority of Patients with Severe Asymptomatic Carotid Stenosis Should Have an Intervention
____________________

William A. Gray, MD
System Chief of Cardiovascular Services
Main Line Health
Co-Director, Lankenau Heart Institute
Wynnewood, Pennsylvania

Carotid Stenting Is the Best Approach for Selected Asymptomatic Patients
____________________

Ross Naylor, MD, FRCS
Professor of Vascular Surgery
Leicester Vascular Institute
Leicester, United Kingdom

Criteria for CEA in Neurologically Asymptomatic Patient

01:16:00